Insider · CIK 0001165970
Sara Grootwassink Lewis
Files at WY (WEYERHAEUSER CO), DOC (HEALTHPEAK PROPERTIES, INC.), FCX (FREEPORT-MCMORAN INC). First filing Apr 28, 2025, latest Dec 18, 2025.
Sara Grootwassink Lewis files SEC Form 4 as director at WY (WEYERHAEUSER CO), and also at DOC (HEALTHPEAK PROPERTIES, INC.), FCX (FREEPORT-MCMORAN INC). Since Apr 28, 2025, Sara Grootwassink Lewis has reported 3 open-market buys worth $313k and 0 open-market sells worth $0, the latest filed on Dec 18, 2025.
A track record needs three past buys with six months of prices behind them; Sara Grootwassink Lewis has 0, so none is measured yet.
The newest scored trade: bought $106k of WY on Dec 17, 2025, filed Dec 18, 2025, scored 35 (weak). In the last 12 months: 1 buy worth $106k and 0 sells worth $0.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
WY: WEYERHAEUSER CO
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
DOC: HEALTHPEAK PROPERTIES, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | WYbuy WEYERHAEUSER CO | $106k 4,500 shares | +21% | +12% from low-22% from high | |
| 45Moderate | WYbuy WEYERHAEUSER CO | $101k 4,000 shares | +23% | +3% from low-24% from high | |
| 64Notable | HEALTHPEAK PROPERTIES, INC. | $106k 6,000 shares | +200% | 0% from low-21% from high |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | FCX FREEPORT-MCMORAN INC | AGrant or award Common Stock | +2,800 | $0.00 | $0 | 34,000 | Jun 2, 2026 |
| May 15, 2026 | WY WEYERHAEUSER CO | AGrant or award Share Equivalentsderivative | +7,832 | $0.00 | $0 | 80,214 | May 19, 2026 |
| May 6, 2026 | DOC HEALTHPEAK PROPERTIES, INC. | AGrant or award Common Stock | +9,744 | $0.00 | $0 | 56,488 | May 7, 2026 |
| Dec 17, 2025 | WY WEYERHAEUSER CO | POpen-market purchase Common | +4,500 | $23.61 | $106k | 25,978 | Dec 18, 2025 |
| Aug 11, 2025 | WY WEYERHAEUSER CO | POpen-market purchase Common | +4,000 | $25.29 | $101k | 21,478 | Aug 13, 2025 |
| Jun 1, 2025 | FCX FREEPORT-MCMORAN INC | AGrant or award Common Stock | +4,900 | $0.00 | $0 | 31,200 | Jun 3, 2025 |
| May 9, 2025 | WY WEYERHAEUSER CO | AGrant or award Share Equivalentsderivative | +6,849 | $26.28 | $180k | 69,947 | May 13, 2025 |
| Apr 25, 2025 | DOC HEALTHPEAK PROPERTIES, INC. | AGrant or award Common Stock | +10,657 | $0.00 | $0 | 46,744 | Apr 29, 2025 |
| Apr 28, 2025 | DOC HEALTHPEAK PROPERTIES, INC. | POpen-market purchase Common Stockindirect: IRA | +6,000 | $17.66 | $106k | 9,000 | Apr 28, 2025 |
Questions about Sara Grootwassink Lewis
Answered from the filings on this page, as of the latest one.
Is Sara Grootwassink Lewis buying or selling?
In the last 12 months Sara Grootwassink Lewis reported 1 open-market buy worth $106k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $106k of WY on Dec 17, 2025. Grants, option exercises and tax withholding are not counted.
How did Sara Grootwassink Lewis's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sara Grootwassink Lewis has 0.
Where does Sara Grootwassink Lewis file Form 4?
Sara Grootwassink Lewis has filed Form 4 at WY (WEYERHAEUSER CO); DOC (HEALTHPEAK PROPERTIES, INC.); FCX (FREEPORT-MCMORAN INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.